Phenobarbital
NDC 67296-1427
Product Information
Phenobarbital is a UNAPPROVED DRUG OTHER-approved product labeled by Redpharm Drug, Inc.. This medication is used alone or with other medications to control seizures. It is supplied as a white product. This product entry covers the primary NDC 67296-1427 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
324
Code Structure Chart
Product Details
What is NDC 67296-1427?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- PHENOBARBITAL (UNII: YQE403BP4D)
- PHENOBARBITAL (UNII: YQE403BP4D) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 199167 - PHENobarbital 32.4 MG Oral Tablet
- RxCUI: 199167 - phenobarbital 32.4 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.
Patient Education
Phenobarbital
Phenobarbital is used to control seizures. Phenobarbital is also used to relieve anxiety. It is also used to prevent withdrawal symptoms in people who are dependent ('addicted'; feel a need to continue taking the medication) on another barbiturate medication and are going to stop taking the medication. Phenobarbital is in a class of medications called barbiturates. It works by slowing activity in the brain.
[Learn More]
* Please review the full disclaimer at the bottom of this page.